Jeevan Scientific Technology Limited (BOM:538837)
India · Delayed Price · Currency is INR 69.00
+0.39 (0.57%)
At close: Feb 13, 2026
BOM:538837 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 503.08 | 468.44 | 396.5 | 361.78 | 677.93 | 474.83 |
Other Revenue | - | - | 0 | - | 7.4 | - |
| 503.08 | 468.44 | 396.51 | 361.78 | 685.33 | 474.83 | |
Revenue Growth (YoY) | 5.13% | 18.14% | 9.60% | -47.21% | 44.33% | 90.70% |
Cost of Revenue | 50.96 | 44.9 | 48.21 | 40.73 | 83.71 | 15.54 |
Gross Profit | 452.12 | 423.54 | 348.3 | 321.05 | 601.61 | 459.29 |
Selling, General & Admin | 209.21 | 173.17 | 158.61 | 154.85 | 225.09 | 139.42 |
Amortization of Goodwill & Intangibles | 14.74 | 14.74 | 16.78 | 13.85 | - | 10.72 |
Other Operating Expenses | 191.18 | 175.85 | 143.5 | 152.5 | 192.04 | 139.57 |
Operating Expenses | 468.44 | 411.54 | 361.4 | 358.08 | 454.02 | 318.77 |
Operating Income | -16.32 | 12.01 | -13.1 | -37.03 | 147.59 | 140.51 |
Interest Expense | -21.83 | -17.67 | -9.68 | -10.18 | -9.13 | -21.99 |
Interest & Investment Income | 5.12 | 5.12 | 5.46 | 9.84 | 1.48 | 5.33 |
Currency Exchange Gain (Loss) | -0.24 | -0.24 | 0.28 | 0.29 | -0.25 | -0.25 |
Other Non Operating Income (Expenses) | 1.9 | 0.17 | 1.01 | 0.26 | 0.25 | 12.89 |
EBT Excluding Unusual Items | -31.37 | -0.6 | -16.04 | -36.83 | 139.95 | 136.5 |
Gain (Loss) on Sale of Investments | - | - | - | - | 40.42 | - |
Gain (Loss) on Sale of Assets | 0.08 | 0.08 | - | - | -0.09 | - |
Pretax Income | -30.26 | 0.51 | -16.04 | -36.83 | 180.28 | 136.5 |
Income Tax Expense | -9.55 | -0.08 | -2.77 | -6.18 | 60.85 | 19.09 |
Earnings From Continuing Operations | -20.71 | 0.59 | -13.27 | -30.65 | 119.44 | 117.4 |
Minority Interest in Earnings | 1.87 | 0.75 | 0.31 | 0.16 | - | - |
Net Income | -18.83 | 1.34 | -12.96 | -30.49 | 119.44 | 117.4 |
Net Income to Common | -18.83 | 1.34 | -12.96 | -30.49 | 119.44 | 117.4 |
Net Income Growth | - | - | - | - | 1.73% | - |
Shares Outstanding (Basic) | 12 | 16 | 15 | 15 | 15 | 15 |
Shares Outstanding (Diluted) | 12 | 16 | 15 | 15 | 15 | 15 |
Shares Change (YoY) | -31.96% | 2.28% | 1.00% | 0.16% | 0.00% | -0.00% |
EPS (Basic) | -1.60 | 0.08 | -0.84 | -1.99 | 7.81 | 7.67 |
EPS (Diluted) | -1.60 | 0.08 | -0.84 | -1.99 | 7.81 | 7.67 |
EPS Growth | - | - | - | - | 1.73% | - |
Free Cash Flow | - | -59.59 | -91.37 | -145.68 | 172.19 | 41.48 |
Free Cash Flow Per Share | - | -3.76 | -5.90 | -9.51 | 11.25 | 2.71 |
Dividend Per Share | - | - | - | - | 1.200 | 0.500 |
Dividend Growth | - | - | - | - | 140.00% | - |
Gross Margin | 89.87% | 90.42% | 87.84% | 88.74% | 87.78% | 96.73% |
Operating Margin | -3.24% | 2.56% | -3.31% | -10.24% | 21.54% | 29.59% |
Profit Margin | -3.74% | 0.29% | -3.27% | -8.43% | 17.43% | 24.73% |
Free Cash Flow Margin | - | -12.72% | -23.04% | -40.27% | 25.12% | 8.74% |
EBITDA | 32.83 | 59.05 | 31.15 | 1.88 | 184.38 | 177.36 |
EBITDA Margin | 6.53% | 12.61% | 7.85% | 0.52% | 26.90% | 37.35% |
D&A For EBITDA | 49.15 | 47.05 | 44.25 | 38.91 | 36.79 | 36.85 |
EBIT | -16.32 | 12.01 | -13.1 | -37.03 | 147.59 | 140.51 |
EBIT Margin | -3.24% | 2.56% | -3.31% | -10.24% | 21.54% | 29.59% |
Effective Tax Rate | - | - | - | - | 33.75% | 13.99% |
Revenue as Reported | 511.33 | 474.96 | 403.25 | 372.52 | 737.18 | 493.45 |
Advertising Expenses | - | 2.35 | 2.79 | 2.25 | 1.59 | 0.68 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.